Highly infectious prions generated by a single round of microplate- based protein misfolding cyclic amplification

mBio

Volumn 5, Issue 1, 2013, Pages

  Moudjou, Mohammed ^a   Sibille, Pierre ^a   Fichet, Guillaume ^a,b   Reine, Fabienne ^a   Chapuis, Jérôme ^a   Herzog, Laetitia ^a   Jaumain, Emilie ^a   Laferrière, Florent ^a   Richard, Charles Adrien ^a   Laude, Hubert ^a   Andréoletti, Olivier ^c   Rezaei, Human ^a   Béringue, Vincent ^a  

^a INRA Institut National de la Recherche Agronomique   (France)

^b Franklab ^*  (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CREUTZFELDT JAKOB DISEASE; GENE AMPLIFICATION; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; RELIABILITY; SENSITIVITY ANALYSIS; SPECIES DIFFERENCE;

ANIMALS; CLINICAL LABORATORY TECHNIQUES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; PRION DISEASES; PRPSC PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 84903370965     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00829-13     Document Type: Article

References (67)

1. Collinge J. 2001. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24:519-550.
2. Diaz-Espinoza R, Soto C. 2012. High-resolution structure of infectious prion protein: the final frontier. Nat. Struct. Mol. Biol. 19:370-377.
3. Colby DW, Prusiner SB. 2011. Prions. Cold Spring Harb. Perspect. Biol 3:a006833. http://dx.doi.org/10.1101/cshperspect.a006833.
4. Knowles TP, Waudby CA, Devlin GL, Cohen SI, Aguzzi A, Vendruscolo M, Terentjev EM, Welland ME, Dobson CM. 2009. An analytical solution to the kinetics of breakable filament assembly. Science 326: 1533-1537.
5. Bessen RA, Marsh RF. 1994. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68:7859-7868.
6. Sim VL, Caughey B. 2009. Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol. Aging 30:2031-2042.
7. Spassov S, Beekes M, Naumann D. 2006. Structural differences between TSEs strains investigated by FT-IR spectroscopy. Biochim. Biophys. Acta 1760:1138-1149.
8. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB. 1996. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
9. Saborio GP, Permanne B, Soto C. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-813.
10. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B. 2007. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat. Methods 4:645-650.
11. Bannach O, Birkmann E, Reinartz E, Jaeger KE, Langeveld JP, Rohwer RG, Gregori L, Terry LA, Willbold D, Riesner D. 2012. Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS One 7:e36620. http://dx.doi.org/10.1371/journal.pone.0036620.
12. Castilla J, Saa P, Soto C. 2005. Detection of prions in blood. Nat. Med. 11:982-985.
13. Lacroux C, Vilette D, Fernandez-Borges N, Litaise C, Lugan S, Morel N, Corbiere F, Simon S, Simmons H, Costes P, Weisbecker JL, Lantier I, Lantier F, Schelcher F, Grassi J, Castilla J, Andreoletti O. 2012. Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J. Virol. 86:2056-2066.
14. Safar JG, Lessard P, Tamguney G, Freyman Y, Deering C, Letessier F, Dearmond SJ, Prusiner SB. 2008. Transmission and detection of prions in feces. J. Infect. Dis. 198:81-89.
15. Castilla J, Gonzalez-Romero D, Saa P, Morales R, De Castro J, Soto C. 2008. Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134:757-768.
16. Klingeborn M, Race B, Meade-White KD, Chesebro B. 2011. Lower specific infectivity of protease-resistant prion protein generated in cellfree reactions. Proc. Natl. Acad. Sci. U. S. A. 108:E1244-E1253.
17. Saa P, Castilla J, Soto C. 2006. Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J. Biol. Chem. 281:35245-35252.
18. Shikiya RA, Bartz JC. 2011. In vitro generation of high-titer prions. J. Virol. 85:13439-13442.
19. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, Kretzschmar HA. 2006. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc. Natl. Acad. Sci. U. S. A. 103: 15818-15823.
20. Daus ML, Wagenfuhr K, Thomzig A, Boerner S, Hermann P, Hermelink A, Beekes M, Lasch P. 25 October 2013. Infrared microspectroscopy detects protein misfolding cyclic amplification (PMCA)-induced conformational alterations in hamster scrapie progeny seeds. J. Biol. Chem. http://dx.doi.org/10.1074/jbc.M113.497131.
21. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, Baskakov IV. 2011. Highly efficient protein misfolding cyclic amplification. PLoS Pathog. 7:e1001277. http:// dx.doi.org/10.1371/journal.ppat.1001277.
22. Johnson CJ, Aiken JM, McKenzie D, Samuel MD, Pedersen JA. 2012. Highly efficient amplification of chronic wasting disease agent by protein misfolding cyclic amplification with beads (PMCAb). PLoS One 7:e35383. http://dx.doi.org/10.1371/journal.pone.0035383.
23. Cosseddu GM, Nonno R, Vaccari G, Bucalossi C, Fernandez-Borges N, Di Bari MA, Castilla J, Agrimi U. 2011. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog. 7:e1002370. http://dx.doi.org/10.1371/journal.ppat.1002370.
24. Langevin C, Andreoletti O, Le Dur A, Laude H, Beringue V. 2011. Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model. Neurobiol. Dis. 41:219-225.
25. Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, Laude H, Beringue V. 2010. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 6:e1000859. http://dx.doi.org/10.1371/journal.ppat.1000859.
26. Castilla J, Saa P, Morales R, Abid K, Maundrell K, Soto C. 2006. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol. 412:3-21.
27. Vilotte JL, Soulier S, Essalmani R, Stinnakre MG, Vaiman D, Lepourry L, Da Silva JC, Besnard N, Dawson M, Buschmann A, Groschup M, Petit S, Madelaine MF, Rakatobe S, Le Dur A, Vilette D, Laude H. 2001. Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP. J. Virol. 75:5977-5984.
28. Dron M, Moudjou M, Chapuis J, Salamat MK, Bernard J, Cronier S, Langevin C, Laude H. 2010. Endogenous proteolytic cleavage of diseaseassociated prion protein to produce C2 fragments is strongly cell-and tissue-dependent. J. Biol. Chem. 285:10252-10264.
29. Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C. 1996. Prion protein (PrP) with aminoproximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1255-1264.
30. Beringue V, Le Dur A, Tixador P, Reine F, Lepourry L, Perret-Liaudet A, Haik S, Vilotte JL, Fontes M, Laude H. 2008. Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS One 3:e1419. http://dx.doi.org/10.1371/ journal.pone.0001419.
31. Gonzalez-Montalban N, Baskakov IV. 2012. Assessment of strainspecific PrP(Sc) elongation rates revealed a transformation of PrP(Sc) properties during protein misfolding cyclic amplification. PLoS One 7:e41210. http://dx.doi.org/10.1371/journal.pone.0041210.
32. Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, Surewicz WK, Safar JG. 2012. Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog. 8:e1002835. http://dx.doi.org/ 10.1371/journal.ppat.1002835.
33. Makarava N, Savtchenko R, Alexeeva I, Rohwer RG, Baskakov IV. 2012. Fast and ultrasensitive method for quantitating prion infectivity titre. Nat. Commun. 3:741. http://dx.doi.org/10.1038/ncomms1730.
34. Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C. 2009. De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog. 5:e1000421. http://dx.doi.org/10.1371/ journal.ppat.1000421.
35. Morales R, Duran-Aniotz C, Diaz-Espinoza R, Camacho MV, Soto C. 2012. Protein misfolding cyclic amplification of infectious prions. Nat. Protoc. 7:1397-1409.
36. Safar JG, DeArmond SJ, Kociuba K, Deering C, Didorenko S, Bouzamondo-Bernstein E, Prusiner SB, Tremblay P. 2005. Prion clearance in bigenic mice. J. Gen. Virol. 86:2913-2923.
37. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, Riesner D. 2005. Search for a prion-specific nucleic acid. J. Virol. 79: 10796-10806.
38. Deleault NR, Kascsak R, Geoghegan JC, Supattapone S. 2010. Speciesdependent differences in cofactor utilization for formation of the protease-resistant prion protein in vitro. Biochemistry 49:3928-3934.
39. Murayama Y, Yoshioka M, Masujin K, Okada H, Iwamaru Y, Imamura M, Matsuura Y, Fukuda S, Onoe S, Yokoyama T, Mohri S. 2010. Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(Sc) and enable ultrasensitive detection of bovine PrP(Sc). PLoS One 5:e13152. http://dx.doi.org/10.1371/ journal.pone.0013152.
40. Thackray AM, Klein MA, Aguzzi A, Bujdoso R. 2002. Chronic subclinical prion disease induced by low-dose inoculum. J. Virol. 76:2510-2517.
41. Bessen RA, Marsh RF. 1992. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 73:329-334.
42. Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T, Lowe J, Mead S, Rudge P, Collinge J, Jackson GS. 2011. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377:487-493.
43. Beringue V, Herzog L, Jaumain E, Reine F, Sibille P, Le Dur A, Vilotte JL, Laude H. 2012. Facilitated cross-species transmission of prions in extraneural tissue. Science 335:472-475.
44. Collinge J. 2012. Cell biology. The risk of prion zoonoses. Science 335: 411-413.
45. Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L, Linehan J, Simmons M, Webb P, Bellerby P, Andrews N, Hilton DA, Ironside JW, Beck J, Poulter M, Mead S, Brandner S. 2013. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675. http:// dx.doi.org/10.1136/bmj.f5675.
46. Kurt TD, Perrott MR, Wilusz CJ, Wilusz J, Supattapone S, Telling GC, Zabel MD, Hoover EA. 2007. Efficient in vitro amplification of chronic wasting disease PrPRES. J. Virol. 81:9605-9608.
47. Mays CE, Titlow W, Seward T, Telling GC, Ryou C. 2009. Enhancement of protein misfolding cyclic amplification by using concentrated cellular prion protein source. Biochem. Biophys. Res. Commun. 388:306-310.
48. Segarra C, Bougard D, Moudjou M, Laude H, Beringue V, Coste J. 2013. Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection. PLoS One 8:e69632. http://dx.doi.org/10.1371/journal.pone.0069632.
49. Bruce ME, McBride PA, Jeffrey M, Scott JR. 1994. PrP in pathology and pathogenesis in scrapie-infected mice. Mol. Neurobiol. 8:105-112.
50. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB. 1997. Selective neuronal targeting in prion disease. Neuron 19:1337-1348.
51. Hecker R, Taraboulos A, Scott M, Pan KM, Yang SL, Torchia M, Jendroska K, DeArmond SJ, Prusiner SB. 1992. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev. 6:1213-1228.
52. Deleault NR, Walsh DJ, Piro JR, Wang F, Wang X, Ma J, Rees JR, Supattapone S. 2012. Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions. Proc. Natl. Acad. Sci. U. S. A. 109:E1938-E1946.
53. Deleault NR, Harris BT, Rees JR, Supattapone S. 2007. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. U. S. A. 104:9741-9746.
54. Wang F, Wang X, Yuan CG, Ma J. 2010. Generating a prion with bacterially expressed recombinant prion protein. Science 327:1132-1135.
55. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, Wadsworth JD. 2008. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem. J. 416:297-305.
56. Owen JP, Maddison BC, Whitelam GC, Gough KC. 2007. Use of thermolysin in the diagnosis of prion diseases. Mol. Biotechnol. 35:161-170.
57. Dickinson AG, Fraser H. 1969. Genetical control of the concentration of ME7 scrapie agent in mouse spleen. J. Comp. Pathol. 79:363-366.
58. Dickinson AG, Meikle VM, Fraser H. 1969. Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J. Comp. Pathol. 79:15-22.
59. Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, Manson JC. 2007. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J. Biol. Chem. 282:35878-35886.
60. Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. 2005. The most infectious prion protein particles. Nature 437:257-261.
61. Laferriere F, Tixador P, Moudjou M, Chapuis J, Sibille P, Herzog L, Reine F, Jaumain E, Laude H, Rezaei H, Beringue V. 2013. Quaternary structure of pathological prion protein as a determining factor of strainspecific prion replication dynamics. PLoS Pathog. 9:e1003702. http:// dx.doi.org/10.1371/journal.ppat.1003702.
62. Orru CD, Wilham JM, Vascellari S, Hughson AG, Caughey B. 2012. New generation QuIC assays for prion seeding activity. Prion 6:147-152.
63. Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B. 2010. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 6:e1001217. http://dx.doi.org/10.1371/ journal.ppat.1001217.
64. McGuire LI, Peden AH, Orru CD, Wilham JM, Appleford NE, Mallinson G, Andrews M, Head MW, Caughey B, Will RG, Knight RS, Green AJ. 2012. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 72:278-285.
65. Cronier S, Beringue V, Bellon A, Peyrin JM, Laude H. 2007. Prion strain-and species-dependent effects of antiprion molecules in primary neuronal cultures. J. Virol. 81:13794-13800.
66. Feraudet C, Morel N, Simon S, Volland H, Frobert Y, Creminon C, Vilette D, Lehmann S, Grassi J. 2005. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J. Biol. Chem. 280:11247-11258.
67. Krasemann S, Groschup MH, Harmeyer S, Hunsmann G, Bodemer W. 1996. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol. Med. 2:725-734.